Jeffrey P. Raimondi
View detailed information about Jeffrey P. Raimondi, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Jeffrey P. Raimondi, including their role, qualifications, and regulatory activities.
Recent Records (25)
Page 1 of 2483 - Gland Pharma Limited, Units I+II Pashamylaram Site
483
483 - First Pharma Associates LLC dba Riverpoint Pharmacy
483
483 - Apitoria Pharma Private Limited
483
483 - Zhejiang Huahai Pharmaceutical Co., Ltd.
483
483 - Optum Compounding Services, LLC
483
483 - NerPharMa S.r.l.
483
483 - Wedgewood Connect, LLC
483
483 - Constant Irwindale, Inc.
483
483_RESPONSE - Wedgewood Connect, LLC
483_RESPONSE
WARNING_LETTER_RESPONSE - Invacare Corporation
WARNING_LETTER_RESPONSE
WARNING_LETTER_RESPONSE - Invacare Corporation
WARNING_LETTER_RESPONSE
WARNING_LETTER_RESPONSE - Invacare Corporation
WARNING_LETTER_RESPONSE
483 - Biocon Sdn. Bhd. (Company No. 201101002193)
483
483 - PharmaEssentia Corporation, Taichung Plant
483
483 - Cardinal Health, Inc.
483
EIR - Boehringer Ingelheim Fremont, Inc.
EIR
EIR - Cosmetic Enterprises Ltd
EIR
483 - Intas Pharmaceuticals Limited
483
483 - Zhejiang Huahai Pharmaceutical Co., Ltd.
483
483 - Lonza Manufacturing LLC
483
Showing 1-20 of 25 records
Related Office
Person Information
Name
Jeffrey P. Raimondi
Degree
B.A.
Title
Consumer Safety Officer
Role
INVESTIGATOR
ID: 7576ca4e-d9e8-4015-9ae6-9498e76058d3
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox